Posted by Michael Wonder on 15 Dec 2024
ARS Pharmaceuticals announces filings for approval of neffy in China, Japan and Australia
12 December 2024 - Licensing partners in key Asia Pacific countries have filed for approval of neffy (epinephrine nasal spray) 2 mg with regulatory agencies
ARS Pharmaceuticals announced today that its licensing partners in China, Japan and Australia have filed for approval of neffy (epinephrine nasal spray) 2 mg in their respective countries.
